ATE380241T1 - Ziel des rnaiii activierenden proteines (trap) - Google Patents

Ziel des rnaiii activierenden proteines (trap)

Info

Publication number
ATE380241T1
ATE380241T1 AT01122636T AT01122636T ATE380241T1 AT E380241 T1 ATE380241 T1 AT E380241T1 AT 01122636 T AT01122636 T AT 01122636T AT 01122636 T AT01122636 T AT 01122636T AT E380241 T1 ATE380241 T1 AT E380241T1
Authority
AT
Austria
Prior art keywords
trap
target
rap
antibody
rnaiii
Prior art date
Application number
AT01122636T
Other languages
English (en)
Inventor
Naomi Balaban
Tzipora Goldkorn
Original Assignee
Naomi Balaban
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Naomi Balaban filed Critical Naomi Balaban
Application granted granted Critical
Publication of ATE380241T1 publication Critical patent/ATE380241T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/305—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F)
    • C07K14/31—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F) from Staphylococcus (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/82—Proteins from microorganisms
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/82—Proteins from microorganisms
    • Y10S530/825—Bacteria

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AT01122636T 1998-09-15 1999-09-13 Ziel des rnaiii activierenden proteines (trap) ATE380241T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10041598P 1998-09-15 1998-09-15
US09/393,862 US6747129B1 (en) 1998-09-15 1999-09-10 Target of RNAIII activating protein(TRAP)

Publications (1)

Publication Number Publication Date
ATE380241T1 true ATE380241T1 (de) 2007-12-15

Family

ID=26797129

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01122636T ATE380241T1 (de) 1998-09-15 1999-09-13 Ziel des rnaiii activierenden proteines (trap)

Country Status (6)

Country Link
US (2) US6747129B1 (de)
EP (1) EP1121380A1 (de)
AT (1) ATE380241T1 (de)
DE (1) DE69937694T2 (de)
ES (1) ES2296694T3 (de)
WO (1) WO2000015660A1 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7323179B2 (en) * 1997-12-19 2008-01-29 Naomi Balaban Methods and compositions for the treatment and prevention of Staphylococcus and other bacterial infections
US20080219976A1 (en) * 1997-12-19 2008-09-11 Naomi Balaban Methods and compositions for treatment and prevention of staphylococcal infections
US7534857B2 (en) * 1997-12-19 2009-05-19 Centegen, Inc. Methods and compositions for the treatment and prevention of staphylococcal infections
AU2001238115A1 (en) * 2000-02-10 2001-08-20 Intermune, Inc. Novel amino acid and peptide inhibitors of staphylococcus virulence
IL138183A0 (en) * 2000-08-31 2001-10-31 Rostam Ltd Ph reducing formulation and delivery system for a tampon
CN1569893A (zh) * 2003-07-21 2005-01-26 中国人民解放军军事医学科学院基础医学研究所 金葡菌毒力因子调控蛋白的抗原表位及其模拟表位和用途
US20050244402A1 (en) * 2004-04-30 2005-11-03 Villanueva Julie M Absorption of pain-causing agents
US20070092572A1 (en) * 2005-04-04 2007-04-26 Naomi Balaban Bone cement compositions and the like comprising an RNAIII-inhibiting peptide
US20070009566A1 (en) * 2005-04-04 2007-01-11 Naomi Balaban Method and apparatus for treating bacterial infections in devices
US7824691B2 (en) * 2005-04-04 2010-11-02 Centegen, Inc. Use of RIP in treating staphylococcus aureus infections
EP1906985A4 (de) * 2005-05-10 2012-07-11 Naomi Balaban Zusammensetzungen zur verabreichung von rnaiii-hemmenden peptiden
CN100540047C (zh) * 2006-04-17 2009-09-16 中国人民解放军军事医学科学院基础医学研究所 Trap蛋白在制备治疗金黄色葡萄球菌感染的药品中的应用
WO2007147098A2 (en) * 2006-06-16 2007-12-21 Tufts University Identification and use of non-peptide analogs of rnaiii-inhibiting peptide for the treatment of staphylococcal infections
WO2008084478A2 (en) * 2007-01-09 2008-07-17 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Anti-bacterial peptides and methods of treating diseases using same
KR100926270B1 (ko) 2007-08-07 2009-11-12 성균관대학교산학협력단 황색 포도상구균 유래 ｔｒａｐ 단백질의 인산화 방법 및인산화 저해제 탐색 방법
CN105254719B (zh) * 2015-10-21 2018-07-13 黑龙江八一农垦大学 金黄色葡萄球菌trap蛋白的cd4+t细胞表位鉴定及其重组表位疫苗

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8308236D0 (en) * 1983-03-25 1983-05-05 Celltech Ltd Dna vectors
US5641503A (en) * 1989-04-27 1997-06-24 Mcneil-Ppc, Inc. Additives to tampons
US5587288A (en) * 1994-05-24 1996-12-24 The Rockefeller University Regulation of exoprotein in Staphylococcus aureus
AU3825995A (en) 1994-10-04 1996-04-26 New York University Blocking expression of virulence factors in s. aureus
WO1997044349A1 (en) 1996-05-22 1997-11-27 New York University BLOCKING EXPRESSION OF VIRULENCE FACTORS IN $i(S. AUREUS)

Also Published As

Publication number Publication date
DE69937694T2 (de) 2008-11-20
US6689878B2 (en) 2004-02-10
ES2296694T3 (es) 2008-05-01
US20020102271A1 (en) 2002-08-01
EP1121380A1 (de) 2001-08-08
WO2000015660A1 (en) 2000-03-23
DE69937694D1 (de) 2008-01-17
WO2000015660A8 (en) 2000-07-20
US6747129B1 (en) 2004-06-08
WO2000015660A9 (en) 2000-08-24

Similar Documents

Publication Publication Date Title
DE69937694D1 (de) Ziel des RNAIII activierenden Proteines (TRAP)
WO2022204316A3 (en) Variant nucleic acid libraries for cd3
FI100472B (fi) Monoklonaalisia vasta-aineita metallikationeille
US8067015B2 (en) Methods and compositions for the treatment and prevention of Staphylococcus and other bacterial infections
DE69330643D1 (de) Monoklonaler antikörper, welcher spezifisch an vaskularisiertes tumorendothelium bindet und verwendungen davon
EP0536275A4 (en) Tissue-derived tumor growth inhibitors, methods of preparation and uses thereof
ATE214942T1 (de) Fibrinogen-bildungsprotein
DK1325033T3 (da) Inhibering af komplement C5 aktivering til behandlingen og forebyggelsen af forsinket xenograf- eller akut vaskulær afstødning
BR9914066A (pt) Polipeptìdio degradador de c3 de complemento humano de streptococcus pneumoniae
NO964650L (no) LAG-3 proteinopploselige polypeptidfraksjoner, fremgangsmate for fremstilling, terapeutisk preparat og anti-idiotype antistoff
GB9606040D0 (en) Active peptide
EA201001190A1 (ru) Выделенное антитело, специфически связанное с полипептидом, состоящее из последовательности аминокислотных остатков
ATE408685T1 (de) Antimikrobielle peptide, abstammend von ubiquicidin
EP1188831A3 (de) Ziel des RNAIII activierenden Proteines (TRAP)
WO2002020619A3 (en) HUMAN ANTIBODIES AGAINST PSEUDOMONAS AERUGINOSA LPS DERIVED FROM TRANSGENIC XENOMOUSE$m(3)
US20060121045A1 (en) Antibody fragments for protection from pathogen infection and methods of use thereof
CA2323091A1 (en) Nephrin gene and protein
EP1862549A3 (de) Target eines RNAIII-aktivierenden Proteins (TRAP)
WO1999057142A3 (en) Vaccine for $i(pseudomonas aeruginosa)
Chronopoulos et al. Binding of ubiquitin to experimentally induced murine AA amyloid
KR100788435B1 (ko) Ⅷ 안티팩터 동종항체
Finnie et al. A comparison of cobra venom factor-induced depletion of serum C3 in eight different strains of mice
NAKAGAWA et al. Characterization of a monoclonal antibody to hog thyroid peroxidase and its use for immunohistochemical localization of the peroxidase in the thyroid gland
EP1177203A4 (de) Kollagen-bindende proteine von enterococcalen bakterien
Reiser et al. Peptide-specific antibodies indicate species heterogeneity of a 42-kDa high-affinity inositol 1, 3, 4, 5-tetrakisphosphate receptor protein from brain

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1188831

Country of ref document: EP